3SBio

Biotechnology Research • Pudong, Shanghai, China • 201-500 Employees

Company overview

Headquarters	No.399 Libing Road Zhangjiang High-tech Park, Shanghai , Shanghai 201203, CN
Phone number	+862425386000
Website	3sbio.com
NAICS	541714
SIC	283
Keywords	肿瘤, 生物制药, 糖尿病, 肾病, 自身免疫, 皮肤科
Founded	1993
Employees	201-500
Socials

Key Contacts at 3SBio

Jiangnan Luo

Director Of Business Development

Kelvin Sun

Group Supply Chain & Procurement Director

Jone Yuan Zhu

国际业务部销售副总监Associate Sales Director Of International Business Depart.

军泉李

Central Marketing Director

Heidi Yang

Independent Non Executive Director

Gerry Ng

Indepedendent Non Executive Director

Zheng Jin

Director Of Research And Development

Michael Li

Executive Quality Director

Sixin Guan

Deputy Director Business Development

斌王

Hr Associate Director

3SBio Email Formats

3SBio uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 54.7% of the time.

Format	Example	Percentage
{first name}.{last name}@company.com	john.doe@company.com	54.7%
{first name initial}{last name}@company.com	{first name initial}doe@company.com	19.2%
{last name}.{first name}@company.com	doe.john@company.com	11.3%
{first name}@company.com	john@company.com	9.1%
{first name}{last name}@company.com	johndoe@company.com	5.7%

About 3SBio

关于三生制药集团三生制药集团是一家集研发、生产和销售为一体的生物制药领军企业，致力于以高品质的药品提高患者生存质量，为人类健康造福。目前，集团拥有80余项国家发明专利授权，30余种上市产品，覆盖肿瘤、自身免疫、肾病、代谢及皮肤科等治疗领域。集团拥有抗体药物国家工程研究中心以及生物药和化药双平台的4大研发中心，共有25种在研产品，其中16种作为国家一类新药正在研发，并拥有符合GMP标准的6大生产基地。未来，三生制药集团将继续秉持“珍爱生命、关注生存、创造生活”的理念，全力打造全球领先的中国生物制药企业。 About 3S Pharmaceutical Group 3S Pharmaceutical Group is a leading bio-pharmaceutical company integrating R&D, production and sales, with a focus on improving the life quality of patients with high-quality medicines to benefit human health. At present, the Group owns more than 80 national invention patents and has launched more than 30 kinds of products into the market, covering several treatment fields, among others, cancer, autoimmune, kidney disease, metabolism and dermatology. The Group owns 4 R&D centers of the National Engineering Research Center of Antibody Medicine and dual platforms for biopharmaceutical and chemical medicine. There are 25 kinds of products under R&D, 16 kinds of them are under R&D as the national first-class new drugs. The Group also owns 6 production bases complying with GMP standards. In the future, 3S Pharmaceutical Group will continue to uphold the concept of “Care for Life, Cherish Life, Create Life” to create a world's leading bio-pharmaceutical company in China.

3SBio revenue & valuation

Annual revenue	$3,433,500,000
Revenue per employee	$8,850,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$10,987,000,000
Total funding	$15,200,000